Skip to content

Exploring the clinical efficacy and mechanism of acupuncture treatment for post-stroke insomnia based on gut microbiota

Exploring the clinical efficacy and mechanism of acupuncture treatment for post-stroke insomnia based on gut microbiota

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000954
Enrollment
Unknown
Registered
2026-04-16
Start date
2025-08-01
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke insomnia

Interventions

Zi Wu Liu Zhu Na Zi Fa Group:Acupuncture

Sponsors

Jiangmen Wuyi Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with insomnia following stroke who meet diagnostic criteria: 2. Patients aged between 40-75 years, with no restriction on gender; 3. Duration of illness between 5 weeks to half a year; 4. Patients with clear consciousness and basically normal cognitive function; 5. Patients who can correctly understand the content of all questionnaires and cooperate with operators and therapists; 6. PSQI total score >7 points; 7. Patients who have not received sedative-hypnotic medications for at least 1 month; 8. Patients who voluntarily agree to participate in this study and consent to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those with a history of sleep disorders or long-term use of sleep aids; 2. Patients with a history of depressive or anxiety disorders, other mental health-related conditions, or long-term use of psychiatric medications; 3. Individuals with severe post-stroke cognitive impairment; 4. Patients who are intolerant to acupuncture therapy; 5. Those with other organic brain lesions or severe conditions of the kidneys, liver, or heart; 6. Individuals who lack understanding of the measurement tools involved in the trial and are unable to cooperate; 7. Participants whom researchers believe may have trial results influenced by other factors or face difficulties in clinical trials.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index Scale;Stroke Quality of Life Scale;

Secondary

MeasureTime frame
5-hydroxytryptamine;Glutamic acid;Gamma-Aminobutyric Acid;

Countries

China

Contacts

Public ContactChen Taian

Jiangmen Wuyi Traditional Chinese Medicine Hospital

786061980@qq.com15068683002

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026